Drug Patent Expirations in December 2011

Drug Patent Expirations in December 2011

*Drugs may be covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
OMNICEF Abbott cefdinir 4,935,507 Dec 4, 2011
AMPYRA Acorda dalfampridine 5,370,879 Dec 6, 2011
AVELOX Bayer Hlthcare moxifloxacin hydrochloride 4,990,517 Dec 8, 2011
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER Bayer Hlthcare moxifloxacin hydrochloride 4,990,517 Dec 8, 2011
ACCOLATE Astrazeneca zafirlukast 6,143,775 Dec 11, 2011
ACCOLATE Astrazeneca zafirlukast 5,319,097 Dec 11, 2011
ACCOLATE Astrazeneca zafirlukast 5,294,636 Dec 11, 2011
MOTRIN Mcneil Ped ibuprofen 5,320,855*PED Dec 14, 2011
TROVAN Pfizer trovafloxacin mesylate 5,164,402 Dec 18, 2011
PALLADONE Purdue Pharma Lp hydromorphone hydrochloride 5,968,551 Dec 24, 2011
PALLADONE Purdue Pharma Lp hydromorphone hydrochloride 6,294,195 Dec 24, 2011
MYCAMINE Astellas micafungin sodium 5,376,634 Dec 27, 2011
PRIALT Azur Pharma Ii ziconotide 5,859,186 Dec 30, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


Leave a Reply